In combination with bortezomib, melphalan and prednisone ... at Week 25 onwards until disease progression. Pre- and post-injection medications, others: see full labeling. Prophylaxis for herpes ...
BORUZU (bortezomib injection), a proteasome inhibitor, is used for the treatment of multiple myeloma and mantle cell lymphoma. This product references the branded product Velcade®, a lyophilized ...
Bortezomib (a proteasome inhibitor) has recently been approved for treatment of relapsed multiple myeloma, a plasma cell neoplasia, owing to the sensitivity of immunoglobulin-synthesizing myeloma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback